Mark Rolfe

In the United States, there are 45 individuals named Mark Rolfe spread across 28 states, with the largest populations residing in California, Florida, Washington.

Public information about Mark Rolfe

Resumes

Mark Rolfe

Location:

3349 northwest 173Rd St, Edmond, OK 73012

Industry:

Medical Practice

Work:

New Lung Associates Feb 2007 - May 2016
Transplant Pulmonologist - Former President

Skills:

Customer Service, Microsoft Office, Management, Microsoft Word, Public Speaking, Research, Leadership, Powerpoint, Healthcare, Strategic Planning

Automotive Technician

Location:

Cromwell, CT

Industry:

Automotive

Work:

Paul's Auto Body May 2015 - Oct 2015
Technician Middletown Nissan May 2015 - Oct 2015
Automotive Technician Barberino Nissan Mar 2014 - Feb 2015
Technician Hallmark Tire Company Feb 2004 - Mar 2014
Technician

Education:

Newington High School

Skills:

Automotive, Customer Satisfaction, Customer Service, Automotive Aftermarket

Fire Controlman

Location:

Great Lakes, IL

Industry:

Military

Work:

Us Navy
Fire Controlman Dataline Jun 2007 - Aug 2008
Field Engineer Silgan Containers May 2006 - Jun 2007
Management Trainee

Education:

Manuel S. Enverga University Foundation - Lucena 1998 - 2003
Bachelor of Engineering, Bachelors, Industrial Engineering

Skills:

Military, Security Clearance, Military Experience, Dod, Leadership, Force Protection, National Security, Defense, Red Hat Linux, Ssds, Naval Instructor Training Course, Troubleshooting, Active Dod Secret Clearance

Certifications:

Navy Instructor Training Course
Center For Personal and Professional Development Learning Site Dam Neck

Field Engineer - Nanolumens

Location:

Chicago, IL

Work:

Field Engineer - Nanolumens

Education:

Manuel S. Enverga University Foundation - Lucena

Owner

Location:

2012 Larrabee Ave, Bellingham, WA 98225

Industry:

Construction

Work:

Rolfe's Plumbing and Heating
Owner

Interests:

Hydronic Heating
Parenting My Kids
Fishing
Shooting
New Technologies
Plumbing
Refrigeration

Senior Vice President

Location:

San Francisco, CA

Industry:

Biotechnology

Work:

Bristol-Myers Squibb
Senior Vice President Celgene
Corporate Vice President Cleave Biosciences Sep 2011 - Feb 2017
President and Chief Scientific Officer Cytomx Therapeutics Sep 2010 - Oct 2011
Chief Scientific Officer Facet Biotech Aug 2009 - May 2011
Senior Vice President and Chief Strategy Officer Takeda Oncology Dec 1999 - Jul 2009
Vice President Discovery Oncology Mitotix Mar 1993 - Nov 1999
Director, Molecular Biology Celltech Sep 1989 - Feb 1993
Principal Scientist, Oncology

Education:

Columbia University Vagelos College of Physicians and Surgeons 1988 - 1989
University of London 1982 - 1985
Doctorates, Doctor of Philosophy, Genetics University of Oxford 1978 - 1982
Masters, Master of Arts, Bachelors, Bachelor of Arts, Biochemistry

Skills:

Drug Discovery, Biotechnology, Cancer, Oncology, Clinical Development, Protein Chemistry, Cell Biology, Antibodies, Immunology, Biomarker Discovery, Lifesciences, Therapists

Mark Rolfe

Location:

Cambridge, MA

Industry:

Biotechnology

Work:

Takeda Oncology
Senior Director

Mark Rolfe

Location:

Lansing, MI

Phones & Addresses

Name

Addresses

Phones

Mark A Rolfe

25820 Old Owen Rd, Monroe, WA 98272

360-863-3543

Mark A Rolfe

9505 245Th Ave, Monroe, WA 98272

360-805-9810

Mark A Rolfe

2202 Ferndale Ter, Ferndale, WA 98248

360-920-7083

Mark B Rolfe

21461 Blue Oak Gulch Rd, Twain Harte, CA 95383

209-586-3241

Mark D Rolfe

11 Michele Ln, Madison, CT 06443

203-421-8612

Mark Z Rolfe

319 S Grace St, Lansing, MI 48917

Mark D Rolfe

90 Robin Ridge Dr, Madison, CT 06443

203-245-1301

Mark E Rolfe

27953 Kale Ave, Turkey River, IA 52052

563-252-2866, 563-252-1193

Business Records

Name / Title

Company / Classification

Phones & Addresses

Mark Rolfe
Medical Director

Maine General Rehabilitation & Nursing Care Inc
Intermediate Care Facility · Intermediate Care Facility Skilled Nursing Care Facility

37 Gray Birch Dr, Augusta, ME 04330
40 Glenridge Dr, Augusta, ME 04330
207-622-6226, 207-626-2600

Mark William Rolfe

Mark Rolfe MD
Pulmonologist · Internist

2 Columbia Dr, Tampa, FL 33606
813-844-4634

Mr Mark Rolfe
Member

Rolfe's Plumbing & Heating LLC
Plumbing Contractors. Heating Contractors

2202 Ferndale Ter, Ferndale, WA 98248
360-920-7083

Mark Colin Rolfe

Mark Rolfe MD
Family Doctor · Internist

149 Main St, Winthrop, ME 04364
207-377-2111

Mark Rolfe
Principal

Lasting Impressions Dollco Inc
Business Services at Non-Commercial Site

6716 Surfside Blvd, Ruskin, FL 33572

Mark W. Rolfe
Director

One Breath at A Time, Inc
Nonprofit Trust Management

1271 Berkshire Ln, Tarpon Springs, FL 34688
3104 N Armenia Ave, Tampa, FL 33607
813-374-2117

Mark Rolfe
Director

Lasting Impressions Doll Company, Incorporated

4747 W Waters Ave, Tampa, FL 33614

Mark Rolfe
Principal

Aircare Inc
Nonclassifiable Establishments

627 Rte 135, Monmouth, ME 04259

Publications

Us Patents

Ubiquitin Conjugating Enzymes

US Patent:

6068982, May 30, 2000

Filed:

Dec 17, 1996

Appl. No.:

8/767942

Inventors:

Mark Rolfe - Newton Upper Falls MA
Maria Isabel Chiu - Boston MA
Guillaume Cottarel - West Roxbury MA
Vivian Berlin - Dunstable MA
Veronique Damagnez - Cambridge MA
Giulio Draetta - Winchester MA

Assignee:

Mitotix, Inc. - Cambridge MA

International Classification:

G01N 3353

US Classification:

435 721

Abstract:

The present invention relates to drug screening assays which provide a systematic and practical approach for the identification of candidate agents able to inhibit ubiquitin-mediated degradation of a cell-cycle regulatory protein, such as p53, p27, myc, fos, MAT. alpha. 2, or cyclins. The invention further relates to novel ubiquitin-conjugating enzymes, and uses related thereto.

Human Ubiquitin Conjugating Enzyme

US Patent:

5981699, Nov 9, 1999

Filed:

May 23, 1994

Appl. No.:

8/247904

Inventors:

Giulio Draetta - Winchester MA
Mark Rolfe - Newton Upper Falls MA
Jens W. Eckstein - Cambridge MA

Assignee:

Mitotix, Inc. - Cambridge MA

International Classification:

C07K 1400
A61K 3900

US Classification:

530350

Abstract:

The present invention concerns a novel human ubiquitin-conjugating enzyme which is implicated in the ubiquitin-mediated inactivation of cell-cycle regulatory proteins, partucularly p53. The present invention makes available diagnostic and therapeutic assays and reagents for detecting and treating transformed cells, such as may be useful in the detection of cancer. The present invention also provides reagents for altering the normal regulation cell proliferation in untransformed cells, such as by upregulating certain cell-cycle checkpoints, e. g. to protect normal cells against DNA damaging reagents.

Components Of Ubiquitin Ligase Complexes, And Uses Related Thereto

US Patent:

6747128, Jun 8, 2004

Filed:

Aug 20, 1997

Appl. No.:

08/915048

Inventors:

Maureen Caligiuri - Reading MA
Mark Rolfe - Newton MA

Assignee:

GPC Biotech, Inc. - Waltham MA

International Classification:

C07K 1400

US Classification:

530350, 4352523, 43525411, 4353201, 435219, 435183, 435325, 536 231, 536 232, 536 235

Abstract:

The present invention relates to the isolation of a new class of ubiquitin ligases involved in protein degradation in vertebrate organisms, such as protein degradation of cell cycle regulatory proteins. Accordingly, the invention provides nucleic acids and the proteins encoded by said nucleic acids which play a role in the ubiquitinylation and subsequent degradation of substrate proteins and in regulating cell proliferation, cell differentiation, and cell survival. The invention also provides methods for modulating protein degradation, cell proliferation, cell differentiation and/or cell survival by modulating protein ubiquitination; assays for identifying compounds which modulate protein degradation, cell proliferation, differentiation and/or cell survival; methods for treating disorders associated with aberrant protein degradation, cell proliferation, cell differentiation, and/or cell survival; and diagnostic and prognostic assays for determining whether a subject is at risk of developing a disorder associated with an aberrant protein degradation, cell proliferation, cell differentiation, and/or survival.

Regulation Of I Kappa B (I.kappa.b) Degradation And Methods And Reagents Related Thereto

US Patent:

6060262, May 9, 2000

Filed:

Jul 16, 1997

Appl. No.:

8/895601

Inventors:

Peter J. Strack - Cambridge MA
Susan J. Glass - Southborough MA
Mark Rolfe - Newton MA

Assignee:

Mitotix, Inc. - Cambridge MA

International Classification:

C12Q 148
C12Q 100
C12Q 137

US Classification:

435 15

Abstract:

E6Ap Antisense Constructs And Methods Of Use

US Patent:

5858987, Jan 12, 1999

Filed:

May 5, 1995

Appl. No.:

8/435637

Inventors:

Giulio Draetta - Winchester MA
Mark Rolfe - Newton Upper Falls MA

Assignee:

Mitotix, Inc. - Cambridge MA

International Classification:

A61K 4800
C07H 2104
C07H 2102
C12Q 168

US Classification:

574 44

Abstract:

The present invention relates to the discovery that antisense nucleic acids complimentary to an E6AP gene can be used to regulate cellular p53 levels. In general the invention features E6AP antisense constructs which, by inhibiting E6AP activity, can modulate cellular p53 levels in both p53+ transformed cells and in normal cells. The invention also provides methods for treating papillomavirus (PV) induced condition, methods for regulating cellular p53 levels and methods for regulating cellular proliferation.

E6Ap-Binding Proteins

US Patent:

7566455, Jul 28, 2009

Filed:

Jun 7, 1995

Appl. No.:

08/484878

Inventors:

Giulio Draetta - Weymouth MA, US
Mark Rolfe - Newton Upper Falls MA, US

Assignee:

GPC Biotech, Inc. - Princeton NJ

International Classification:

A61K 39/00

US Classification:

4241851

Abstract:

The present invention relates to the discovery in eukaryotic cells, particularly human cells, of novel protein-protein interactions between certain cellular proteins, referred to herein as “E6AP-binding proteins” or “E6AP-BPs”, and the cellular protein E6AP, the latter of which is a component of a ubiquitin-ligase (E3) enzyme. The association of E6AP and the subject E6AP-binding proteins implicates the E6AP-binding proteins in a number of basic cellular functions, such as regulation of gene expression, regulation of the cell-cycle, modification of cell surface receptors, biogenesis of ribosomes, and DNA repair. One of the E6AP-binding proteins shares certain homology with the papillomavirus E6 protein, which also binds E6AP.

Ubiquitin Conjugating Enzymes

US Patent:

5968761, Oct 19, 1999

Filed:

Jun 7, 1995

Appl. No.:

8/486663

Inventors:

Mark Rolfe - Newton Upper Falls MA
Maria Isabel Chiu - Boston MA
Guillaume Cottarel - West Roxbury MA
Vivian Berlin - Dunstable MA
Veronique Damagnez - Cambridge MA
Giulio Draetta - Winchester MA

Assignee:

Mitotix, Inc. - Cambridge MA

International Classification:

C12Q 148
C12N 910

US Classification:

435 15

Abstract:

Ubiquitin Conjugating Enzymes

US Patent:

5744343, Apr 28, 1998

Filed:

Sep 13, 1994

Appl. No.:

Author:

Shlomo Aloni

Publisher:

Osprey Publishing

Binding:

Paperback

Pages:

ISBN #:

1841762946

EAN Code:

9781841762944

When the UN called for the end of the British mandate and the partition of Palestine into two independent states, the RAF found itself under attack from both sides. Tracing the development of hostilities in the Middle East, this book covers the period from the establishment of the first proper Israe...

Videos & Images

FAQ: Learn more about Mark Rolfe

What is Mark Rolfe's current residential address?

Mark Rolfe's current known residential address is: 5584 Tina, Dayton, OH 45424. Please note this is subject to privacy laws and may not be current.

What are the previous addresses of Mark Rolfe?

Previous addresses associated with Mark Rolfe include: 319 S Grace St, Lansing, MI 48917; 5130 Camden Rd, Madison, WI 53716; 5 Overlook Cir, Sedalia, CO 80135; 900 Minnesota St Unit 115, San Francisco, CA 94107; 18114 73Rd Ave E, Puyallup, WA 98375. Remember that this information might not be complete or up-to-date.

Where does Mark Rolfe live?

Dayton, OH is the place where Mark Rolfe currently lives.

How old is Mark Rolfe?

Mark Rolfe is 61 years old.

What is Mark Rolfe date of birth?

Mark Rolfe was born on 1963.

What is the main specialties of Mark Rolfe?

Mark is a Family Medicine

Where has Mark Rolfe studied?

Mark studied at University of Vermont (1998)

What is Mark Rolfe's email?

Mark Rolfe has such email addresses: cro***@msn.com, mro***@netzero.net, rolf***@alpinecom.net, cmue1***@aol.com, maro***@hotmail.com, mark.ro***@aol.com. Note that the accuracy of these emails may vary and they are subject to privacy laws and restrictions.

What is Mark Rolfe's telephone number?

Mark Rolfe's known telephone numbers are: 360-920-7083, 415-796-3299, 513-536-7138, 207-458-1072, 303-506-0928, 813-631-1737. However, these numbers are subject to change and privacy restrictions.

Who is Mark Rolfe related to?

Known relatives of Mark Rolfe are: Tammy Stookey, Allen Stookey, Hollie Rolfe, Maryellen Rolfe, Gregory Currie, Melanie Currie, Terry Yuraitis. This information is based on available public records.

Name Variants	Marc Rolfe	Marcus Rolfe	Markus Rolfe
Ages	39 to 73
Phones	360-920-7083	415-796-3299	513-536-7138
Addresses	2202 Ferndale Ter, Ferndale, WA 98248	319 S Grace St, Lansing, MI 48917	5130 Camden Rd, Madison, WI 53716
Business records	Deputy Commissioner / Connecticut Department of Transportation	Operations Supervisor / Abf Freight	Senior Vice President / Bristol-Myers Squibb

Mark Rolfe

What do we know about Mark Rolfe

Public information about Mark Rolfe

Resumes

Resumes

Mark Rolfe

Automotive Technician

Fire Controlman

Field Engineer - Nanolumens

Owner

Senior Vice President

Mark Rolfe

Mark Rolfe

Phones & Addresses

Business Records

Publications

Us Patents

Ubiquitin Conjugating Enzymes

Human Ubiquitin Conjugating Enzyme

Components Of Ubiquitin Ligase Complexes, And Uses Related Thereto

Regulation Of I Kappa B (I.kappa.b) Degradation And Methods And Reagents Related Thereto

E6Ap Antisense Constructs And Methods Of Use

E6Ap-Binding Proteins

Ubiquitin Conjugating Enzymes

Ubiquitin Conjugating Enzymes

Amazon

Air War In The Gulf 1991(Osprey Combat Aircraft 27)

British And Empire Aces Of World War I (Osprey Aircraft Of The Aces No 45)

Conflict In The Balkans 1991-2000 (Osprey Combat Aircraft 24)

B-24 Liberator Units Of The Pacific War (Osprey Combat Aircraft 11)

B-24 Liberator Units Of The Fifteenth Air Force (Osprey Combat Aircraft 21)

French Aces Of World War 2 (Osprey Aircraft Of The Aces No 28)

B-24 Liberator Units Of The Eighth Air Force (Osprey Combat Aircraft 15)

Arab-Israeli Air Wars 1947-1982 (Osprey Combat Aircraft 23)

FAQ: Learn more about Mark Rolfe

Possible Relatives

Mark Rolfe from other States